• All News
• 2019
• 2017
• 2016
• 2015
• 2014

Xenetic Biosciences Announces Pricing of $3.1 Million Registered Direct Offering

Mar 5, 2019

Xenetic Biosciences, Inc. (NASDAQ: XBIO) Announces Agreement to Acquire Innovative CAR T Technology Platform

Mar 4, 2019

Xenetic Biosciences Reports 2017 Third Quarter Financial Results and Provides Corporate Update

Nov 15, 2017

Xenetic Biosciences Enters Into Sublicense Agreement Related to its PolyXen™ Technology with Baxalta Inc., a Wholly-owned Subsidiary of Shire plc

Nov 2, 2017

Xenetic Biosciences Appoints Jeffrey F. Eisenberg as Chief Executive Officer

Oct 31, 2017

Xenetic Biosciences Provides Update on Annual Meeting of Stockholders

Oct 2, 2017

Xenetic Biosciences Announces Dismissal of Annual Meeting of Stockholders

Aug 23, 2017

Xenetic Biosciences Reports 2017 Second Quarter Financial Results and Provides Business Update

Aug 15, 2017

Xenetic Biosciences Announces Appointment of Three Directors to the Board

Aug 14, 2017

Xenetic Biosciences Announces Adjournment of Annual Meeting of Stockholders until Wednesday, August 16, 2017

Jul 18, 2017

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• Next »